DEACONESS HENDERSON HOSPITAL
1. Target Overview & Investment Thesis
DEACONESS HENDERSON HOSPITAL is a 118-bed suburban community hospital in HENDERSON, KY with $127.3M in net patient revenue and a 6.2% operating margin. The hospital serves a payer mix of 25.4% Medicare, 1.9% Medicaid, and 72.7% commercial.
Thesis: Turnaround. Our ML models identify $9.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.2% to 13.5% (+736bps).
| Net Revenue HCRIS | $127.3M |
| Current EBITDA COMPUTED | $7.9M |
| Operating Margin COMPUTED | 6.2% |
| Occupancy HCRIS | 29.7% |
| Revenue / Bed COMPUTED | $1.1M |
| Net-to-Gross HCRIS | 33.0% |
| Distress Probability ML | 52.8% |
2. Market Context & Competitive Position
KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 6.2% places it above the state median. Among 41 size-comparable peers (59-236 beds), the median margin is 0.7%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (59-236), prioritizing same-state peers. 41 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| DEACONESS HENDERSON HOSPITAL (Target) | KY | 118 | $127.3M | 6.2% |
| BAPTIST HEALTH PADUCAH | KY | 190 | $391.7M | -0.5% |
| MERCY HEALTH LOURDES HOSPITAL | KY | 178 | $288.1M | 7.7% |
| BAPTIST HEALTH CORBIN | KY | 197 | $285.4M | 1.4% |
| LAKE CUMBERLAND REGIONAL HOSP | KY | 179 | $278.7M | 5.6% |
| BAPTIST HEALTH MADISONVILLE | KY | 154 | $220.0M | -5.7% |
| ST. ELIZABETH FLORENCE | KY | 134 | $212.6M | 8.8% |
| SAINT JOSEPH EAST | KY | 138 | $209.5M | 2.6% |
| EPHRAIM MCDOWELL REG MED CTR | KY | 157 | $207.7M | -13.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.7M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.5M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.5M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $81K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $7.9M |
| + RCM Uplift | +$9.4M |
| Pro Forma EBITDA | $17.2M |
| Current Margin | 6.2% |
| Pro Forma Margin | 13.5% |
| WC Released (1x) | $4.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $12.1M | $145.7M | 12.02x | 64.4% |
| Base (11x exit) | 10.0x | 11.0x | $12.1M | $164.2M | 13.55x | 68.4% |
| Bull Case | 9.0x | 11.0x | $10.9M | $199.0M | 18.25x | 78.7% |
| Bull (12x exit) | 9.0x | 12.0x | $10.9M | $220.3M | 20.20x | 82.4% |
| Bear Case | 11.0x | 10.0x | $13.3M | $94.9M | 7.12x | 48.1% |
| Bear (11x exit) | 11.0x | 11.0x | $13.3M | $108.7M | 8.15x | 52.1% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Low occupancy | At 29.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 52.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 41 hospitals with 59-236 beds
- Same-state prioritization (n=42)
- Comp margins: P25=-9.6% / P50=0.7% / P75=10.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.